GeneNews selected to present late-breaking abstract at AACR Annu...(irtually any disease ormedical condition...)
Navigation Links
| HOME >> BIOLOGY >> TECHNOLOGY |
GeneNews selected to present late-breaking abstract at AACR Annual Meeting
Date:3/17/2008
irtually any disease or medical condition from a simple blood sample. GeneNews is currently applying the Sentinel Principle in major areas with unmet clinical needs such as cancer, arthritis, cardiovascular disease and neurological disorders. GeneNews' first product in development, ColonSentry, is a convenient and patient-friendly blood-based biomarker test that can identify the current risk of colorectal cancer. For more information on GeneNews, visit http://www.genenews.com.
This press release contains forward-looking statements, which reflect the Company's current expectations regarding future events. The forward-looking statements involve risks and uncertainties. Actual events could differ materially from those projected herein. Investors should consult the Company's ongoing quarterly filings and annual reports for additional information on risks and uncertainties relating to these forward-looking statements. The reader is cautioned not to rely on these forward-looking statements. The Company disclaims any obligation to update these forward-looking statements.
'/>"/>
| SOURCE GeneNews Limited Copyright©2008 PR Newswire. All rights reserved |
Related biology technology :
1. GeneNews receives ISO 13485 accreditation
2. GeneNews initiates patient sample accrual for validation studies of colon cancer blood test
3. GeneNews Chief Scientist Dr. C.C. Liew co-editor of new genomics reference book
4. GeneNews CSO Dr. CC Liew awarded state honour by the Government of Malaysia
5. ARIUS announces five abstracts selected for presentation at 2008 AACR Annual Meeting
6. ThermoGenesis Corp. Announces Voluntary Recall of Selected Lots of AXP Bag Sets
7. New Technology for Early Detection of Lung Cancer Selected for Clinical Study With Veterans
8. Center for Molecular Medicine Selected to Provide DNA Analysis for Childrens Oncology Group Leukemia Study
9. CYIG Awarded Chinas "Top 100 Enterprises" in New Pharmaceuticals, Selected as National "Torch Plan Key High-Tech Enterprise"
10. Raven biotechnologies, inc. and Wyeth Pharmaceuticals Extend Evaluation Period of Selected Raven Antibodies
11. Thermo Fisher Scientific Selected by China Doping Control Center to Supply Testing Instrumentation for the 2008 Olympic Games in Beijing
Post Your Comments:
Breaking Biology Technology:Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 2Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 3Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 4NEI Awards a Two-Year $2.18 Million SBIR Grant to Aciont 2NEI Awards a Two-Year $2.18 Million SBIR Grant to Aciont 3Brooks Instrument Appoints Mike Bayda as Global Level Product Manager 2Brooks Instrument Appoints Mike Bayda as Global Level Product Manager 3
[0] Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans[0] For Release: Esco Announces 2nd North American Facility in Marietta, OH [0] NEI Awards a Two-Year $2.18 Million SBIR Grant to Aciont [0] Brooks Instrument Appoints Mike Bayda as Global Level Product Manager
Other Biology Technology:TechnoJungle to highlight learning, innovation 2Software ONE merges with Swiss firm 2
Breaking Biology News(10 mins):University of Texas Southwestern Medical Center researcher wins Avanti Award in lipids 2University of California, San Francisco, researcher receives ASBMB-Merck Award 2Vermicompost from pig manure grows healthy hibiscus 2Astellas Names Head of Global R 26D Operations 48444 1Astellas Names Head of Global R 26D Operations 48444 2Spectrum Names Katherine Maynard Chief Operating Officer 48441 1Spectrum Names Katherine Maynard Chief Operating Officer 48441 2Craneware to Highlight Best Practices for Optimizing Revenue Capture Processes in Two Seminar Presentations during HFMAs 2009 ANI 3A The Healthcare Fi 48438 1Craneware to Highlight Best Practices for Optimizing Revenue Capture Processes in Two Seminar Presentations during HFMAs 2009 ANI 3A The Healthcare Fi 48438 2
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |